The Functional Genomics Shared Resource (FGSR) of Vanderbilt-lngram Cancer Center (VICC) provides cancer center members with cutting-edge services and support related to a battery of contemporary genomic technologies including microarray, deep-sequencing, and RNAi screening efforts. The resource was formally established in 2000 as the Vanderbilt Microarray Shared Resource (VMSR), and began by offering limited services based principally on spotted cDNA microarrays and a handful of Affymetrix products. Due to strong interest among Vanderbilt faculty and aggressive management, the VMSR grew quickly, both in terms of its user base and the menu of services it offered. Because genomic technologies are naturally suited for analysis of cancer-relevant processes, and because VICC members were among the most active users of the VMSR, the resource was proposed and favorably reviewed (""""""""Outstanding"""""""" rating) as a formal VICC shared resource in the 2004 CCSG renewal as the DNA Microarray shared resource. Since that fime, the resource has been in an almost constant state of evolufion to keep pace with the highly dynamic nature of genomic technologies, ensuring that VICC members have access to the most contemporary and powerful technologies in this area. Our goal is to provide """"""""one-stop shopping"""""""" for scientiflc services related to the analysis or manipulation of genefic informafion. Reflecting this goal, the resource was renamed in September 2009 as the Functional Genomics Shared Resource (FGSR), an appropriate recognifion of the fact that modern genomic studies no longer are solely microarray-based, but rather encompass microarray, high-throughput quantitative PCR, and deep sequencing approaches, as well as high-content efforts for gene/pathway identiflcation via RNAi screening. Although the name and capabilifies of the resource have changed over the years, our mission to comprehensively support the genomic needs of VICC investigators with the most efficient and effective technologies available remains unchanged. The FGSR now provides a comprehensive and centralized resource to support a wide variety of genomic studies, with services ranging from nucleic acid quality control to sample processing utilizing a diverse collection of analysis platforms for DNA and RNA discovery, to high-end analysis and statistical support of the resulting data sets.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-18
Application #
8733541
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
18
Fiscal Year
2014
Total Cost
$243,217
Indirect Cost
$89,303
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Gilchuk, Pavlo; Kuzmina, Natalia; Ilinykh, Philipp A et al. (2018) Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity 49:363-374.e10
Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208
Bangaru, Sandhya; Zhang, Heng; Gilchuk, Iuliia M et al. (2018) A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun 9:2669
Means, Anna L; Freeman, Tanner J; Zhu, Jing et al. (2018) Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer. Cell Mol Gastroenterol Hepatol 6:257-276
Du, Zhenfang; Lovly, Christine M (2018) Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer 17:58
Zhang, Qin; Jeppesen, Dennis K; Higginbotham, James N et al. (2018) Mutant KRAS Exosomes Alter the Metabolic State of Recipient Colonic Epithelial Cells. Cell Mol Gastroenterol Hepatol 5:627-629.e6
Elion, David L; Cook, Rebecca S (2018) Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment. Oncotarget 9:29007-29017
Kook, Seunghyi; Qi, Aidong; Wang, Ping et al. (2018) Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes. Am J Respir Cell Mol Biol 58:566-574
Choksi, Yash A; Reddy, Vishruth K; Singh, Kshipra et al. (2018) BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11:1363-1374
Cooke, Allison L; Morris, Jamie; Melchior, John T et al. (2018) A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J Lipid Res 59:1244-1255

Showing the most recent 10 out of 2462 publications